Read the full stored bill text
89(R) HB 923 - Enrolled version - Bill Text
H.B. No. 923
AN ACT
relating to the Texas Medical Disclosure Panel.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 74.102, Civil Practice and Remedies
Code, is amended by amending Subsections (b), (c), (d), and (h) and
adding Subsections (f-1) and (i) to read as follows:
(b) The disclosure panel established herein is
administratively attached to the [
Texas Department of
] Health
and
Human Services Commission
. The
commission
[
Texas Department of
Health
], at the request of the disclosure panel, shall provide
administrative assistance to the panel; and the
commission
[
Texas
Department of Health
] and the disclosure panel shall coordinate
administrative responsibilities in order to avoid unnecessary
duplication of facilities and services. The
commission
[
Texas
Department of Health
], at the request of the panel, shall submit the
panel's budget request to the legislature. The panel shall be
subject, except where inconsistent, to the rules and procedures of
the
commission
[
Texas Department of Health
]; however, the duties
and responsibilities of the panel as set forth in this chapter shall
be exercised solely by the disclosure panel, and the
executive
commissioner of the commission
[
board
] or
the commission
[
Texas
Department of Health
] shall have no authority or responsibility
with respect to same.
(c) The disclosure panel is composed of
13
[
nine
] members,
with
three members representing the public, at least one of whom has
a background in health literacy,
three members licensed to practice
law in this state
, at least one of whom has experience representing
patients and at least one of whom has experience representing
physicians or health care providers,
and
seven
[
six
] members
licensed to practice medicine in this state. Members of the
disclosure panel shall be selected by the
executive
commissioner of
the Health and Human Services Commission
[
health
].
(d) At the expiration of the term of each member of the
disclosure panel so appointed, the
executive
commissioner
of the
Health and Human Services Commission
shall select a successor, and
such successor shall serve for a term of six years, or until
that
member's
[
his
] successor is selected. Any member who is absent for
three consecutive meetings without the consent of a majority of the
disclosure panel present at each such meeting may be removed by the
executive
commissioner at the request of the disclosure panel
submitted in writing and signed by the chairman. Upon the death,
resignation, or removal of any member, the
executive
commissioner
shall fill the vacancy by selection for the unexpired portion of the
term.
(f-1)
The disclosure panel may not take any action requiring
a vote of the panel unless a majority of the members appointed to
serve on the panel as members licensed to practice medicine in this
state are in attendance at the meeting when the vote is taken.
(h) Employees of the [
Texas Department of
] Health
and Human
Services Commission
shall serve as the staff for the panel.
(i)
When appointing panel members representing the public,
the executive commissioner of the Health and Human Services
Commission may not appoint a registered lobbyist, a health care
provider or the spouse of a health care provider, or a person who
works in any health care-related field, including health insurance.
The executive commissioner shall give preference to persons with
experience in advocating for the public interest.
SECTION 2. The heading to Section 74.103, Civil Practice
and Remedies Code, is amended to read as follows:
Sec. 74.103. DUTIES OF DISCLOSURE PANEL
; LIMITATIONS ON
AUTHORITY
.
SECTION 3. Section 74.103, Civil Practice and Remedies
Code, is amended by adding Subsection (e) to read as follows:
(e)
The panel is not authorized to take any action that
changes the scope of practice authority of any physician or health
care provider.
SECTION 4. Not later than January 1, 2026, the executive
commissioner of the Health and Human Services Commission shall
appoint new members to the Texas Medical Disclosure Panel in
accordance with Section 74.102, Civil Practice and Remedies Code,
as amended by this Act.
SECTION 5. This Act takes effect September 1, 2025.
______________________________
______________________________
President of the Senate
Speaker of the House
I certify that H.B. No. 923 was passed by the House on April
30, 2025, by the following vote: Yeas 109, Nays 29, 1 present, not
voting.
______________________________
Chief Clerk of the House
I certify that H.B. No. 923 was passed by the Senate on May
20, 2025, by the following vote: Yeas 30, Nays 1.
______________________________
Secretary of the Senate
APPROVED: _____________________
Date
_____________________
Governor